US Patent Issued to Disc Medicine, Abb Vie, Abb Vie Deutschland on July 22 for "Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis" (American, German Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,729, issued on July 22, was assigned to Disc Medicine Inc. (Watertown, Mass.), Abb Vie Inc. (North Chicago, Ill.) and Abb Vie Deutschland Gmbh & Co. KG (Wiesbaden, Germany).

"Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis" was invented by Maria Beconi (Cambridge, Mass.), John Quisel (Cambridge, Mass.), Brian MacDonald (Bend, Ore.), Steven Robinette (Fremont, N.H.), Bernhard Mueller (Hannover, Germany), Andreas Popp (Sprockhovel, Germany) and Jennifer M. Perez (Worcester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibr...